CA Stock MarketDetailed Quotes
INNO InnoCan Pharma Corp
- 0.215
- -0.005-2.27%
15min DelayPost Market Oct 15 15:18 ET
61.42MMarket Cap-10238P/E (TTM)
0.220High0.215Low66.50KVolume0.220Open0.220Pre Close14.63KTurnover0.41052wk High0.03%Turnover Ratio285.69MShares0.18552wk Low-0.021EPS TTM47.37MFloat Cap1.650Historical HighLossP/E (Static)220.34MShs Float0.050Historical Low-0.023EPS LYR2.27%Amplitude--Dividend TTM9.35P/B1Lot Size--Div YieldTTM
About InnoCan Pharma Corp Company
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Company Profile
SymbolINNO
Company NameInnoCan Pharma Corp
Founded2018
MarketCNQ
Employees11
Fiscal Year Ends12-31
Address1015, 926 - 5 Avenue SW
CityCalgary
CountryCAN
Zip CodeT2P 0N7
Phone+1 403 777-1519
Company Executives
- Name
- Position
- Salary
- Iris Bincovich
- Chief Executive Officer and Director
- --
- Ron Mayron
- Executive Chairman of the Board
- --
- Joshua Lintern
- Director
- --
- Eyal Kalo
- Research and Development Director
- --
- Peter Bloch
- Director
- --
- Eyal Flom
- Director
- --
- Roni Kamhi
- Director and Member of the Management Board
- --
- Ralph C.l. Bossino
- Director
- --
- Nelson Halpern
- Member of Management Board
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data